Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Allergy Therapeutics Plc	HHU	31. mai 2024	0.05	+13.04
Alliance Pharma plc	DVL	31. mai 2024	0.42	-3.20
Aspen Pharmacare Holdings Ltd	LDZU	31. mai 2024	10.80	-2.70
Aspen Pharmacare Holdings Ltd	LDZA	31. mai 2024	11.20	-1.75
Astellas Pharma Inc.	YPH	31. mai 2024	8.81	+0.69
Astellas Pharma Inc.	YPHA	31. mai 2024	8.60	0.00
BAIYUNSHAN PH	GU5	31. mai 2024	2.56	0.00
Bayer AG	BAYA	31. mai 2024	6.70	+2.29
Beximco Pharmaceuticals Limited	R2WA	31. mai 2024	0.44	-2.21
Cann Group Limited	CVJ	31. mai 2024	0.03	0.00
Cannabis Poland S.A.	8TE	31. mai 2024	0.13	+0.15
CanSino Biologics Inc.	CJH	31. mai 2024	2.30	-10.16
Chemical Works of Gedeon Richter Plc.	RIG2	31. mai 2024	24.00	+1.18
China Resources Pharmaceutical Group Limited	640	31. mai 2024	0.69	0.00
Chugai Pharmaceutical Co Ltd	CUP	31. mai 2024	27.42	+1.37
CMS	2M7C	31. mai 2024	0.77	-2.53
CONSUN PHARMA	C1P	31. mai 2024	0.80	+1.27
COSMO Pharmaceuticals N.V.	C43	31. mai 2024	71.00	0.00
CSPC PHARMA	CVG	31. mai 2024	0.78	-1.67
CSPC Pharmaceuticals Group Ltd American Depositary Receipts	CVGU	31. mai 2024	3.08	+4.05
Daiichi Sankyo Co., Ltd.	D4S	31. mai 2024	32.23	+2.32
Eco Animal Health Group Plc	LWA	31. mai 2024	1.42	+1.43
Eisai Co Ltd	EII	31. mai 2024	38.81	+1.17
Elixinol Global Ltd Ordinary Shares (Australia)	E8M	31. mai 2024	0.00	0.00
FOSUN PHARMA	08HH	31. mai 2024	1.45	-1.30
FUDANZHANGJIANG	FDY	31. mai 2024	0.23	-0.85
Fuji Pharma Co., Ltd.	FUP	31. mai 2024	8.65	+3.59
Genomma Lab Internacional SAB	GEKA	31. mai 2024	0.98	+4.79
Hisamitsu Pharmaceutical Co Ltd	HPX	31. mai 2024	21.40	+1.90
Invion Limited	7C8	31. mai 2024	0.00	0.00

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.